Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Prog Neurobiol ; 217: 102333, 2022 10.
Article in English | MEDLINE | ID: mdl-35872219

ABSTRACT

The neurotrophin brain-derived neurotrophic factor (BDNF) stimulates adult neurogenesis, but also influences structural plasticity and function of serotonergic neurons. Both, BDNF/TrkB signaling and the serotonergic system modulate behavioral responses to stress and can lead to pathological states when dysregulated. The two systems have been shown to mediate the therapeutic effect of antidepressant drugs and to regulate hippocampal neurogenesis. To elucidate the interplay of both systems at cellular and behavioral levels, we generated a transgenic mouse line that overexpresses BDNF in serotonergic neurons in an inducible manner. Besides displaying enhanced hippocampus-dependent contextual learning, transgenic mice were less affected by chronic social defeat stress (CSDS) compared to wild-type animals. In parallel, we observed enhanced serotonergic axonal sprouting in the dentate gyrus and increased neural stem/progenitor cell proliferation, which was uniformly distributed along the dorsoventral axis of the hippocampus. In the forced swim test, BDNF-overexpressing mice behaved similarly as wild-type mice treated with the antidepressant fluoxetine. Our data suggest that BDNF released from serotonergic projections exerts this effect partly by enhancing adult neurogenesis. Furthermore, independently of the genotype, enhanced neurogenesis positively correlated with the social interaction time after the CSDS, a measure for stress resilience.


Subject(s)
Brain-Derived Neurotrophic Factor , Serotonergic Neurons , Animals , Antidepressive Agents , Brain-Derived Neurotrophic Factor/metabolism , Fluoxetine/metabolism , Fluoxetine/pharmacology , Hippocampus/metabolism , Mice , Mice, Transgenic , Neurogenesis/physiology , Serotonergic Neurons/metabolism
2.
Neuropsychopharmacology ; 44(8): 1377-1388, 2019 07.
Article in English | MEDLINE | ID: mdl-30532004

ABSTRACT

Endocannabinoid signaling via anandamide (AEA) is implicated in a variety of neuronal functions and considered a promising therapeutic target for numerous emotion-related disorders. The major AEA degrading enzyme is fatty acid amide hydrolase (FAAH). Genetic deletion and pharmacological inhibition of FAAH reduce anxiety and improve emotional responses and memory in rodents and humans. Complementarily, the mechanisms and impact of decreased AEA signaling remain to be delineated in detail. In the present study, using the Cre/loxP system combined with an adeno-associated virus (AAV)-mediated delivery system, FAAH was selectively overexpressed in hippocampal CA1-CA3 glutamatergic neurons of adult mice. This approach led to specific FAAH overexpression at the postsynaptic site of CA1-CA3 neurons, to increased FAAH enzymatic activity, and, in consequence, to decreased hippocampal levels of AEA and palmitoylethanolamide (PEA), but the levels of the second major endocannabinoid 2-arachidonoyl glycerol (2-AG) and of oleoylethanolamide (OEA) were unchanged. Electrophysiological recordings revealed an enhancement of both excitatory and inhibitory synaptic activity and of long-term potentiation (LTP). In contrast, excitatory and inhibitory long-term depression (LTD) and short-term synaptic plasticity, apparent as depolarization-induced suppression of excitation (DSE) and inhibition (DSI), remained unaltered. These changes in hippocampal synaptic activity were associated with an increase in anxiety-like behavior, and a deficit in object recognition memory and in extinction of aversive memory. This study indicates that AEA is not involved in hippocampal short-term plasticity, or eLTD and iLTD, but modulates glutamatergic transmission most likely via presynaptic sites, and that disturbances in this process impair learning and emotional responses.


Subject(s)
Arachidonic Acids/physiology , Emotions/physiology , Endocannabinoids/physiology , Ethanolamines/metabolism , Glutamic Acid/physiology , Hippocampus/physiology , Learning/physiology , Neuronal Plasticity/physiology , Palmitic Acids/metabolism , Amides , Amidohydrolases/biosynthesis , Amidohydrolases/genetics , Animals , Arachidonic Acids/metabolism , Endocannabinoids/metabolism , Glycerides/metabolism , Hippocampus/metabolism , Long-Term Potentiation/physiology , Long-Term Synaptic Depression/physiology , Male , Memory/physiology , Mice , Neurons/physiology , Oleic Acids , Polyunsaturated Alkamides/metabolism , Synaptic Transmission/physiology , Up-Regulation
3.
Cereb Cortex ; 28(12): 4454-4471, 2018 12 01.
Article in English | MEDLINE | ID: mdl-30307491

ABSTRACT

Neural stem cells (NSCs) in the adult mouse hippocampus occur in a specific neurogenic niche, where a multitude of extracellular signaling molecules converges to regulate NSC proliferation as well as fate and functional integration. However, the underlying mechanisms how NSCs react to extrinsic signals and convert them to intracellular responses still remains elusive. NSCs contain a functional endocannabinoid system, including the cannabinoid type-1 receptor (CB1). To decipher whether CB1 regulates adult neurogenesis directly or indirectly in vivo, we performed NSC-specific conditional inactivation of CB1 by using triple-transgenic mice. Here, we show that lack of CB1 in NSCs is sufficient to decrease proliferation of the stem cell pool, which consequently leads to a reduction in the number of newborn neurons. Furthermore, neuronal differentiation was compromised at the level of dendritic maturation pointing towards a postsynaptic role of CB1 in vivo. Deteriorated neurogenesis in NSC-specific CB1 knock-outs additionally resulted in reduced long-term potentiation in the hippocampal formation. The observed cellular and physiological alterations led to decreased short-term spatial memory and increased depression-like behavior. These results demonstrate that CB1 expressed in NSCs and their progeny controls neurogenesis in adult mice to regulate the NSC stem cell pool, dendritic morphology, activity-dependent plasticity, and behavior.


Subject(s)
Hippocampus/physiology , Long-Term Potentiation , Neural Stem Cells/physiology , Neurogenesis , Receptor, Cannabinoid, CB1/physiology , Animals , Behavior, Animal , Hippocampus/cytology , Male , Mice, Inbred C57BL , Mice, Transgenic , Neural Stem Cells/cytology , Receptor, Cannabinoid, CB1/genetics , Spatial Memory/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...